PCSS-MOUD On-Demand Webinar: Medications for Opioid Use Disorder in Jails, Prisons, and Reentry: Evidence and Practical Approaches-Presentation

Video Transcription

Video Summary

The presentation addresses opioid use disorder (OUD) treatment in correctional settings, emphasizing medication-assisted treatment (MOUD) for justice-involved individuals. It outlines the prevalence of OUD among incarcerated populations, the heightened risk of overdose post-release, and the underutilization of MOUD in jails and prisons. The discussion highlights legal and policy developments, like litigation and Medicaid changes, promoting MOUD access. Evidence shows MOUD increases post-release treatment engagement and reduces opioid use and overdoses. The presentation covers key medications—methadone, buprenorphine, and naltrexone—highlighting their effectiveness and challenges, such as diversion. It stresses individualized treatment plans and the importance of implementing transition strategies to ensure continuity of care post-release. The discussion includes practical approaches to minimize diversion, such as direct observation of medication intake and use of long-acting injections. The team-based approach involving healthcare providers, peers, and correctional staff is critical for effective implementation. The overarching message is that offering MOUD is lifesaving, and efforts must continue to standardize and broaden treatment access across varied correctional facilities.

Keywords

methamphetamine

addiction treatment

novel strategy

cardiovascular issues

contingency management

motivational interviewing

naloxone

bupropion

fentanyl

opioid use disorder

medication-assisted treatment

correctional settings

post-release overdose

MOUD access

transition strategies

legal developments

team-based approach